Brief: NeuroMetrix Announces Peer-Reviewed Publication Of Controlled Trial Of Wearable Neurostimulation Technology
26/07/2021 15:24
July 26 (Reuters) - NeuroMetrix Inc NURO.O :
* NEUROMETRIX ANNOUNCES PEER-REVIEWED PUBLICATION OF A
RANDOMIZED
CONTROLLED TRIAL OF ITS WEARABLE NEUROSTIMULATION TECHNOLOGY FOR
TREATMENT OF FIBROMYALGIA
Source text for Eikon: ID:nGNXb9n03G
Further company coverage: NURO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NeuroMetrix
See all newsBrief: Neurometrix To Be Acquired By Electrocore
Brief: Neurometrix Reiterates Its Review Of Strategic Alternatives
Brief: NeuroMetrix Announces Steps Taken To Enhance Shareholder Value
Brief: Ephraim Fields Reports 9.3% Stake In Neurometrix, Inc. As Of Feb 23, 2024 - SEC Filing
Brief: RS Fund Reports 14.4% Stake In Neurometrix Inc As Of Feb 13